50
Participants
Start Date
May 1, 2025
Primary Completion Date
May 1, 2027
Study Completion Date
May 1, 2027
68Ga-MY6349 PET/CT
Each participant will receive an intravenous injection of 68Ga-MY6349 and undergo PET/CT imaging at baseline and following two and/or four cycles of Trop2-ADC therapy.
RECRUITING
The First Affiliated Hospital of Xiamen University, Xiamen
The First Affiliated Hospital of Xiamen University
OTHER